| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |